Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

GUTSGUTS
Showing 8 of 10 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in FRACTYL HEALTH INC

No. Citadel Advisors exited its GUTS (Fractyl Health) position in Q2 2026. Its Q1 2026 13F listed 48,196 shares worth $22,064. Citadel Advisors already held GUTS in its Q1 2024 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.1M

Total Shares Change

-822,830

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$9.53
0
2026-Q1
Decreased
48,196
-79.0%
$22,0640.0%$5.50
0
2025-Q4
Decreased
228,985
-87.2%
$503,7670.0%$26.40
0
2025-Q3
New
1.8M
-
$2.8M0.0%$19.08
36
2025-Q2
Exited
0
-100.0%
$00.0%$19.44
0
2025-Q1
Decreased
100,345
-86.3%
$119,4110.0%$14.28
0
2024-Q4
Decreased
732,009
-11.0%
$1.5M0.0%$24.72
0
2024-Q3
Increased
822,830
+4.1%
$2.1M0.0%$30.36
27

Other major holders of GUTS: MAVERICK CAPITAL LTD, VANGUARD GROUP INC, MARSHALL WACE, LLP, Woodline Partners LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used